<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10383397" created="30/06/2006" creator="Noriko Katsu"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10383397</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="3-deazaadenosine" sem="Organic_compound_other">3-deazaadenosine</term>, a <term id="T2" lex="S-adenosylhomocysteine_hydrolase_inhibitor" sem="Organic_compound_other"><term id="T3" lex="S-adenosylhomocysteine_hydrolase" sem="Protein_molecule">S-adenosylhomocysteine hydrolase</term> inhibitor</term>, has dual effects on <term id="T4" lex="NF-kappaB_regulation" sem="Other"><term id="T5" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> regulation</term>.</sentence>
<event KT="Fact" id="E1">
<type class="Negative_regulation"/>
<theme idref="T3"/>
<cause idref="T1"/>
<clue>3-deazaadenosine, a S-adenosylhomocysteine hydrolase <clueType>inhibitor</clueType>, has dual effects on NF-kappaB regulation.</clue>
<comment>CAUTION: T1, correctly &quot;3-Deazaadenosine&quot;</comment></event>
<event id="E2">
<type class="Regulation"/>
<theme idref="E3"/>
<cause idref="T1"/>
<clue>3-deazaadenosine, a S-adenosylhomocysteine hydrolase inhibitor, has dual <clueType>effects</clueType> <linkTheme>on</linkTheme> NF-kappaB regulation.</clue>
</event>
<event id="E3">
<type class="Regulation"/>
<theme idref="T5"/>
<clue>3-deazaadenosine, a S-adenosylhomocysteine hydrolase inhibitor, has dual effects on NF-kappaB <clueType>regulation</clueType>.</clue>
</event>
<sentence id="S2">Inhibition of <term id="T6" lex="NF-kappaB_transcriptional_activity" sem="Other"><term id="T7" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> transcriptional activity</term> and promotion of <term id="T8" lex="IkappaBalpha_degradation" sem="Other"><term id="T9" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> degradation</term>.</sentence>
<event KT="Investigation" id="E4">
<type class="Negative_regulation"/>
<theme idref="E35"/>
<clue><clueType>Inhibition</clueType> <linkTheme>of</linkTheme> NF-kappaB transcriptional activity and promotion of IkappaBalpha degradation.</clue>
</event>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<cause idref="T7"/>
<clue>Inhibition of NF-kappaB <clueType>transcriptional activity</clueType> and promotion of IkappaBalpha degradation.</clue>
<comment>NO THEME</comment></event>
<event KT="Investigation" id="E5">
<type class="Positive_regulation"/>
<theme idref="E6"/>
<clue>Inhibition of NF-kappaB transcriptional activity and <clueType>promotion</clueType> <linkTheme>of</linkTheme> IkappaBalpha degradation.</clue>
</event>
<event KT="Other" id="E6">
<type class="Protein_catabolism"/>
<theme idref="T9"/>
<clue>Inhibition of NF-kappaB transcriptional activity and promotion of IkappaBalpha <clueType>degradation</clueType>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S3">Previously we reported that <term id="T10" lex="3-deazaadenosine" sem="Organic_compound_other">3-deazaadenosine</term> (<term id="A1" sem="Organic_compound_other">DZA</term>), a potent inhibitor and substrate for <term id="T11" lex="S-adenosylhomocysteine_hydrolase" sem="Protein_molecule">S-adenosylhomocysteine hydrolase</term> inhibits bacterial <term id="T12" lex="lipopolysaccharide-induced_transcription" sem="Other"><term id="A2" sem="Lipid">lipopolysaccharide</term>-induced transcription</term> of <term id="T13" lex="tumor_necrosis_factor-alpha" sem="Protein_molecule"><term id="A4" sem="DNA_domain_or_region">tumor necrosis factor-alpha</term></term> and <term id="T14" lex="interleukin-1beta" sem="Protein_molecule"><term id="A5" sem="DNA_domain_or_region">interleukin-1beta</term></term> in <term id="T15" lex="mouse_macrophage_RAW_264.7_cell" sem="Cell_cultured">mouse macrophage RAW 264.7 cells</term>.</sentence>
<event KT="Analysis" Source="Other" id="E7">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="A1"/>
<clue><clueSource>Previously</clueSource> we <clueKT>reported</clueKT> that 3-deazaadenosine (DZA), a potent inhibitor and substrate for S-adenosylhomocysteine hydrolase <clueType>inhibits</clueType> bacterial lipopolysaccharide-induced transcription of tumor necrosis factor-alpha and interleukin-1beta in mouse macrophage RAW 264.7 cells.</clue>
</event>
<event KT="Analysis" Source="Other" id="E8">
<type class="Negative_regulation"/>
<theme idref="E9"/>
<cause idref="A1"/>
<clue><clueSource>Previously</clueSource> we <clueKT>reported</clueKT> that 3-deazaadenosine (DZA), a potent inhibitor and substrate for S-adenosylhomocysteine hydrolase <clueType>inhibits</clueType> bacterial lipopolysaccharide-induced transcription of tumor necrosis factor-alpha and interleukin-1beta in mouse macrophage RAW 264.7 cells.</clue>
</event>
<event KT="Other" id="E9">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="A2"/>
<clue>Previously we reported that 3-deazaadenosine (DZA), a potent inhibitor and substrate for S-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-<clueType>induced</clueType> transcription of tumor necrosis factor-alpha and interleukin-1beta in mouse macrophage RAW 264.7 cells.</clue>
</event>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="A2"/>
<clue>Previously we reported that 3-deazaadenosine (DZA), a potent inhibitor and substrate for S-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-<clueType>induced</clueType> transcription of tumor necrosis factor-alpha and interleukin-1beta in mouse macrophage RAW 264.7 cells.</clue>
</event>
<event KT="Other" id="E11">
<type class="Transcription"/>
<theme idref="A4"/>
<clue>Previously we reported that 3-deazaadenosine (DZA), a potent inhibitor and substrate for S-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-induced <clueType>transcription</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha and interleukin-1beta <clueLoc>in mouse macrophage RAW 264.7 cells</clueLoc>.</clue>
</event>
<event KT="Other" id="E12">
<type class="Transcription"/>
<theme idref="A5"/>
<clue>Previously we reported that 3-deazaadenosine (DZA), a potent inhibitor and substrate for S-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-induced <clueType>transcription</clueType> <linkTheme>of</linkTheme> tumor necrosis factor-alpha and interleukin-1beta <clueLoc>in mouse macrophage RAW 264.7 cells</clueLoc>.</clue>
</event>
<event KT="Fact" Manner="High" id="E36">
<type class="Negative_regulation"/>
<cause idref="A1"/>
<clue>Previously we reported that 3-deazaadenosine (DZA), a <clueManner>potent</clueManner> <clueType>inhibitor</clueType> and substrate for S-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-induced transcription of tumor necrosis factor-alpha and interleukin-1beta in mouse macrophage RAW 264.7 cells.</clue>
<comment>NO THEME</comment></event>
<event KT="Other" id="E37">
<type class="Metabolism"/>
<theme idref="A1"/>
<clue>Previously we reported that 3-deazaadenosine (DZA), a potent inhibitor and <clueType>substrate</clueType> for S-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-induced transcription of tumor necrosis factor-alpha and interleukin-1beta in mouse macrophage RAW 264.7 cells.</clue>
</event>
<event KT="Fact" id="E44">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="T11"/>
<clue>Previously we reported that 3-deazaadenosine (DZA), a potent inhibitor and substrate <linkCause>for</linkCause> S-adenosylhomocysteine hydrolase inhibits bacterial lipopolysaccharide-induced transcription of tumor necrosis factor-alpha and interleukin-1beta in mouse macrophage RAW 264.7 cells.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S4">In this study, we demonstrate the effects of <term id="T16" lex="DZA" sem="Organic_compound_other">DZA</term> on <term id="T17" lex="nuclear_factor-kappaB_(NF-kappaB)_regulation" sem="Other"><term id="T18" lex="nuclear_factor-kappaB" sem="Protein_complex">nuclear factor-kappaB</term> (<term id="T19" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>) regulation</term>.</sentence>
<event KT="Analysis" id="E13">
<type class="Regulation"/>
<theme idref="E14"/>
<cause idref="T16"/>
<clue>In this study, we <clueKT>demonstrate</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> DZA <linkTheme>on</linkTheme> nuclear factor-kappaB (NF-kappaB) regulation.</clue>
</event>
<event KT="Other" id="E14">
<type class="Regulation"/>
<theme idref="T19"/>
<clue>In this study, we demonstrate the effects of DZA on nuclear factor-kappaB (NF-kappaB) <clueType>regulation</clueType>.</clue>
</event>
<sentence id="S5"><term id="T20" lex="DZA" sem="Organic_compound_other">DZA</term> inhibits the transcriptional activity of <term id="T21" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> through the hindrance of <term id="T22" lex="p65_(Rel-A)_phosphorylation" sem="Other"><term id="T23" lex="p65" sem="Protein_complex">p65</term> (<term id="T24" lex="Rel-A" sem="Protein_complex">Rel-A</term>) phosphorylation</term> without reduction of its nuclear translocation and <term id="T25" lex="DNA_binding_activity" sem="Other"><term id="A6" sem="DNA_domain_or_region">DNA</term> binding activity</term>.</sentence>
<event id="E15">
<type class="Negative_regulation"/>
<theme idref="E38"/>
<cause idref="E16"/>
<clue>DZA <clueType>inhibits</clueType> the transcriptional activity of NF-kappaB <linkCause>through</linkCause> the hindrance of p65 (Rel-A) phosphorylation without reduction of its nuclear translocation and DNA binding activity.</clue>
</event>
<event KT="Other" id="E38">
<type class="Positive_regulation"/>
<cause idref="T21"/>
<clue>DZA inhibits the <clueType>transcriptional activity</clueType> <linkCause>of</linkCause> NF-kappaB through the hindrance of p65 (Rel-A) phosphorylation without reduction of its nuclear translocation and DNA binding activity.</clue>
<comment>NO THEME</comment></event>
<event id="E16">
<type class="Negative_regulation"/>
<theme idref="E17"/>
<cause idref="T20"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the <clueType>hindrance</clueType> <linkTheme>of</linkTheme> p65 (Rel-A) phosphorylation without reduction of its nuclear translocation and DNA binding activity.</clue>
</event>
<event KT="Other" id="E17">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T24"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the hindrance of p65 (Rel-A) <clueType>phosphorylation</clueType> without reduction of its nuclear translocation and DNA binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E18">
<type class="Negative_regulation"/>
<theme idref="E19"/>
<cause idref="T20"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the hindrance of p65 (Rel-A) phosphorylation <cluePolarity>without</cluePolarity> <clueType>reduction</clueType> <linkTheme>of</linkTheme> its nuclear translocation and DNA binding activity.</clue>
</event>
<event id="E19">
<type class="Localization"/>
<theme idref="T21"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the hindrance of p65 (Rel-A) phosphorylation without reduction of <corefTheme>its</corefTheme> <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> and DNA binding activity.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Negative_regulation"/>
<theme idref="E39"/>
<cause idref="T20"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the hindrance of p65 (Rel-A) phosphorylation <cluePolarity>without</cluePolarity> <clueType>reduction</clueType> <linkTheme>of</linkTheme> its nuclear translocation and DNA binding activity.</clue>
</event>
<event id="E39">
<type class="Binding"/>
<theme idref="T21"/>
<theme idref="A6"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the hindrance of p65 (Rel-A) phosphorylation without reduction of <corefTheme>its</corefTheme> nuclear translocation and DNA <clueType>binding</clueType> activity.</clue>
</event>
<event id="E40">
<type class="Correlation"/>
<theme idref="E15"/>
<theme idref="E18"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the hindrance of p65 (Rel-A) phosphorylation <linkTheme>without</linkTheme> reduction of its nuclear translocation and DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<event id="E41">
<type class="Correlation"/>
<theme idref="E15"/>
<theme idref="E20"/>
<clue>DZA inhibits the transcriptional activity of NF-kappaB through the hindrance of p65 (Rel-A) phosphorylation <linkTheme>without</linkTheme> reduction of its nuclear translocation and DNA binding activity.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S6">The inhibitory effect of <term id="T26" lex="DZA" sem="Organic_compound_other">DZA</term> on <term id="T27" lex="NF-kappaB_transcriptional_activity" sem="Other"><term id="T28" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> transcriptional activity</term> is potentiated by the addition of <term id="T29" lex="homocysteine" sem="Amino_acid_monomer">homocysteine</term>.</sentence>
<event id="E21">
<type class="Negative_regulation"/>
<theme idref="E42"/>
<cause idref="T26"/>
<clue>The <clueType>inhibitory</clueType> effect <linkCause>of</linkCause> DZA <linkTheme>on</linkTheme> NF-kappaB transcriptional activity is potentiated by the addition of homocysteine.</clue>
</event>
<event KT="Other" id="E42">
<type class="Positive_regulation"/>
<cause idref="T28"/>
<clue>The inhibitory effect of DZA on NF-kappaB <clueType>transcriptional activity</clueType> is potentiated by the addition of homocysteine.</clue>
<comment>NO THEME</comment></event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T29"/>
<clue>The inhibitory effect of DZA on NF-kappaB transcriptional activity is <clueType>potentiated</clueType> <linkCause>by</linkCause> the addition of homocysteine.</clue>
</event>
<sentence id="S7">Taken together, <term id="T30" lex="DZA" sem="Organic_compound_other">DZA</term> promotes the proteolytic degradation of <term id="T31" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term>, but not <term id="T32" lex="IkappaBbeta" sem="Protein_molecule">IkappaBbeta</term>, resulting in an increase of <term id="T33" lex="DNA_binding_activity" sem="Other"><term id="A7" sem="DNA_domain_or_region">DNA</term> binding activity</term> of <term id="T34" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> in the <term id="T35" lex="nucleus" sem="Cell_component">nucleus</term> in the absence of its <term id="T36" lex="transcriptional_activity" sem="Other">transcriptional activity</term> in <term id="T37" lex="RAW_264.7_cell" sem="Cell_cultured">RAW 264.7 cells</term>.</sentence>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="E25"/>
<cause idref="T30"/>
<clue>Taken together, DZA <clueType>promotes</clueType> the proteolytic degradation of IkappaBalpha, but not IkappaBbeta, resulting in an increase of DNA binding activity of NF-kappaB in the nucleus in the absence of its transcriptional activity in RAW 264.7 cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E24">
<type class="Positive_regulation"/>
<theme idref="E26"/>
<cause idref="T30"/>
<clue>Taken together, DZA <clueType>promotes</clueType> the proteolytic degradation of IkappaBalpha, but <cluePolarity>not</cluePolarity> IkappaBbeta, resulting in an increase of DNA binding activity of NF-kappaB in the nucleus in the absence of its transcriptional activity in RAW 264.7 cells.</clue>
</event>
<event id="E25">
<type class="Protein_catabolism"/>
<theme idref="T31"/>
<clue>Taken together, DZA promotes the <clueType>proteolytic degradation</clueType> <linkTheme>of</linkTheme> IkappaBalpha, but not IkappaBbeta, resulting in an increase of DNA binding activity of NF-kappaB in the nucleus in the absence of its transcriptional activity in RAW 264.7 cells.</clue>
</event>
<event KT="Other" assertion="non-exist" id="E26">
<type class="Protein_catabolism"/>
<theme idref="T32"/>
<clue>Taken together, DZA promotes the <clueType>proteolytic degradation</clueType> <linkTheme>of</linkTheme> IkappaBalpha, but not IkappaBbeta, resulting in an increase of DNA binding activity of NF-kappaB in the nucleus in the absence of its transcriptional activity in RAW 264.7 cells.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<cause idref="E25"/>
<clue>Taken together, DZA promotes the proteolytic degradation of IkappaBalpha, but not IkappaBbeta, resulting in an <clueType>increase</clueType> <linkTheme>of</linkTheme> DNA binding activity of NF-kappaB in the nucleus in the absence of its transcriptional activity in RAW 264.7 cells.</clue>
</event>
<event id="E28">
<type class="Binding"/>
<theme idref="T34"/>
<theme idref="A7"/>
<clue>Taken together, DZA promotes the proteolytic degradation of IkappaBalpha, but not IkappaBbeta, resulting in an increase of DNA <clueType>binding</clueType> activity <linkTheme>of</linkTheme> NF-kappaB <clueLoc>in the nucleus</clueLoc> in the absence of its transcriptional activity in RAW 264.7 cells.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E34">
<type class="Correlation"/>
<theme idref="E27"/>
<theme idref="T36"/>
<clue>Taken together, DZA promotes the proteolytic degradation of IkappaBalpha, but not IkappaBbeta, resulting in an increase of DNA binding activity of NF-kappaB in the nucleus <linkTheme>in the <cluePolarity>absence</cluePolarity> of</linkTheme> its transcriptional activity <clueLoc>in RAW 264.7 cells</clueLoc>.</clue>
<comment>NO CLUETYPE</comment></event>
<sentence id="S8">The reduction of <term id="T38" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> by <term id="T39" lex="DZA" sem="Organic_compound_other">DZA</term> is neither involved in <term id="T40" lex="IkappaB_kinase_complex_activation" sem="Other"><term id="T41" lex="IkappaB_kinase_complex" sem="Protein_complex">IkappaB kinase complex</term> activation</term> nor modulated by the addition of <term id="T42" lex="homocysteine" sem="Amino_acid_monomer">homocysteine</term>.</sentence>
<event id="E29">
<type class="Negative_regulation"/>
<theme idref="T38"/>
<cause idref="T39"/>
<clue>The <clueType>reduction</clueType> <linkTheme>of</linkTheme> IkappaBalpha <linkCause>by</linkCause> DZA is neither involved in IkappaB kinase complex activation nor modulated by the addition of homocysteine.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E30">
<type class="Regulation"/>
<theme idref="E31"/>
<cause idref="E29"/>
<clue>The reduction of IkappaBalpha by DZA is <cluePolarity>neither</cluePolarity> <clueType>involved</clueType> <linkTheme>in</linkTheme> IkappaB kinase complex activation nor modulated by the addition of homocysteine.</clue>
</event>
<event KT="Other" id="E31">
<type class="Positive_regulation"/>
<theme idref="T41"/>
<clue>The reduction of IkappaBalpha by DZA is neither involved in IkappaB kinase complex <clueType>activation</clueType> nor modulated by the addition of homocysteine.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E32">
<type class="Regulation"/>
<theme idref="E29"/>
<cause idref="T42"/>
<clue>The reduction of IkappaBalpha by DZA is neither involved in IkappaB kinase complex activation <cluePolarity>nor</cluePolarity> <clueType>modulated</clueType> <linkCause>by</linkCause> the addition of homocysteine.</clue>
</event>
<sentence id="S9">This study strongly suggests that <term id="T43" lex="DZA" sem="Organic_compound_other">DZA</term> may be a potent drug for the treatment of <term id="A3" sem="Other">diseases</term> in which <term id="T44" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term> plays a central pathogenic role, as well as a useful tool for studying the regulation and <term id="T45" lex="physiological_function" sem="Other">physiological functions</term> of <term id="T46" lex="NF-kappaB" sem="Protein_complex">NF-kappaB</term>.</sentence>
<event KT="Other" id="E43" uncertainty="probable">
<type class="Regulation"/>
<cause idref="A3"/>
<clue>This study strongly suggests that DZA may be a potent drug for the treatment of diseases <linkTheme>in</linkTheme> which NF-kappaB <clueType>plays</clueType> a central pathogenic <clueType>role</clueType>, as well as a useful tool for studying the regulation and physiological functions of NF-kappaB.</clue>
</event>
<event KT="Investigation" id="E33" uncertainty="doubtful">
<type class="Regulation"/>
<cause idref="T46"/>
<clue>This study strongly suggests that DZA may be a potent drug for the treatment of diseases in which NF-kappaB plays a central pathogenic role, as well as a useful tool for <clueKT>studying</clueKT> the <clueType>regulation</clueType> and physiological functions <linkCause>of</linkCause> NF-kappaB.</clue>
<comment>NO THEME</comment></event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
